A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine

• Main Authors: Rong Tang (Author), Guifan Li (Author), Chengfu Zhang (Author), Hengkui Zhi (Author), Jiahong Zhu (Author), Jianjun Wang (Author), Qi Liang (Author), Yuemei Hu (Author), Changgui Li (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2020-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

This phase Ⅱ, randomized, controlled trial aimed to evaluate the safety and immunogenicity of a various Sabin IPV preparations. Six hundred infants aged 60 ~ 90 days received one of five different vaccines: low- (group A), medium- (group B) or high-D antigen content (group C) of an experimental Sabi...